ECCO2R对COPD加重期呼吸功的生理评价。

IF 2.2 4区 医学 Q3 RESPIRATORY SYSTEM COPD: Journal of Chronic Obstructive Pulmonary Disease Pub Date : 2024-12-01 Epub Date: 2024-12-05 DOI:10.1080/15412555.2024.2436169
Nicholas A Barrett, Francesco Murgolo, Salvatore Grasso, Eirini Kostakou, Nicholas Hart, Patrick Murphy, Abdel Douiri, Luigi Camporota
{"title":"ECCO2R对COPD加重期呼吸功的生理评价。","authors":"Nicholas A Barrett, Francesco Murgolo, Salvatore Grasso, Eirini Kostakou, Nicholas Hart, Patrick Murphy, Abdel Douiri, Luigi Camporota","doi":"10.1080/15412555.2024.2436169","DOIUrl":null,"url":null,"abstract":"<p><strong>Rationale: </strong>The impact of extracorporeal carbon dioxide removal (ECCO<sub>2</sub>R) on work of breathing and aeration in exacerbations of chronic obstructive pulmonary disease (AECOPD) is poorly understood.</p><p><strong>Objectives: </strong>The study explores the impact of non-invasive ventilation (NIV) and ECCO<sub>2</sub>R on respiratory drive, effort and distribution of ventilation in AECOPD.</p><p><strong>Methods: </strong>Patients enrolled in a randomised controlled study of the addition of ECCO<sub>2</sub>R to NIV compared with NIV underwent oesophageal pressure measurement, electrical impedance tomography and parasternal electromyography.</p><p><strong>Measurements and main results: </strong>18 patients were enrolled, nine in each arm. Of these, eight in the NIV arm and seven in the ECCO<sub>2</sub>R arm underwent physiological assessment. Patients randomised to ECCO<sub>2</sub>R, had a period of NIV combined with ECCO<sub>2</sub>R and, after removal of NIV, a period of ECCO<sub>2</sub>R alone. The removal of NIV whilst remaining on ECCO<sub>2</sub>R resulted in a respiratory acidosis (pH 7.34 (7.31-7.34) vs. 7.31 (7.31-7.34), <i>p</i> < 0.0001), increased work of breathing (7.43 (6.08-10.19) vs. 11.1 (8.11-15.15) J/min, <i>p</i> < 0.0001) and increased neural drive (884.4 (684.7-967.3) vs. 1321.1 (903.3-1575.3) AU, <i>p</i> = 0.0005). On day 1, the work of breathing was lower in the NIV than the ECCO<sub>2</sub>R group (4.38 (2.76-7.27) vs. 8.03 (4.8-15.94) J/min, <i>p</i> < 0.0001), minute ventilation was higher (15.54 (13.14-18.48) vs. 12.24 (8.51-13.9) L/min, <i>p</i> < 0.0001) and neural drive was the same (1,163.8 (1,085.5-1,325.5) vs. 1,093.8 (885.7-1,258.7) AU, <i>p</i> = 0.5556).</p><p><strong>Conclusions: </strong>The combination of NIV and ECCO<sub>2</sub>R results in lower work of breathing and improved neuro-ventilatory coupling. NIV fully supports ventilation early whilst ECCO<sub>2</sub>R improves neuro-ventilatory coupling and work of breathing over time.</p><p><strong>Trial registration: </strong>Clinicaltrials.gov; NCT02086084; registered 1 December 2015; https://clinicaltrials.gov/study/NCT02086084?cond=copd&term=ecco2r&rank=4.</p>","PeriodicalId":10704,"journal":{"name":"COPD: Journal of Chronic Obstructive Pulmonary Disease","volume":"21 1","pages":"2436169"},"PeriodicalIF":2.2000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Physiological Assessment of ECCO<sub>2</sub>R on the Work of Breathing in Exacerbations of COPD.\",\"authors\":\"Nicholas A Barrett, Francesco Murgolo, Salvatore Grasso, Eirini Kostakou, Nicholas Hart, Patrick Murphy, Abdel Douiri, Luigi Camporota\",\"doi\":\"10.1080/15412555.2024.2436169\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Rationale: </strong>The impact of extracorporeal carbon dioxide removal (ECCO<sub>2</sub>R) on work of breathing and aeration in exacerbations of chronic obstructive pulmonary disease (AECOPD) is poorly understood.</p><p><strong>Objectives: </strong>The study explores the impact of non-invasive ventilation (NIV) and ECCO<sub>2</sub>R on respiratory drive, effort and distribution of ventilation in AECOPD.</p><p><strong>Methods: </strong>Patients enrolled in a randomised controlled study of the addition of ECCO<sub>2</sub>R to NIV compared with NIV underwent oesophageal pressure measurement, electrical impedance tomography and parasternal electromyography.</p><p><strong>Measurements and main results: </strong>18 patients were enrolled, nine in each arm. Of these, eight in the NIV arm and seven in the ECCO<sub>2</sub>R arm underwent physiological assessment. Patients randomised to ECCO<sub>2</sub>R, had a period of NIV combined with ECCO<sub>2</sub>R and, after removal of NIV, a period of ECCO<sub>2</sub>R alone. The removal of NIV whilst remaining on ECCO<sub>2</sub>R resulted in a respiratory acidosis (pH 7.34 (7.31-7.34) vs. 7.31 (7.31-7.34), <i>p</i> < 0.0001), increased work of breathing (7.43 (6.08-10.19) vs. 11.1 (8.11-15.15) J/min, <i>p</i> < 0.0001) and increased neural drive (884.4 (684.7-967.3) vs. 1321.1 (903.3-1575.3) AU, <i>p</i> = 0.0005). On day 1, the work of breathing was lower in the NIV than the ECCO<sub>2</sub>R group (4.38 (2.76-7.27) vs. 8.03 (4.8-15.94) J/min, <i>p</i> < 0.0001), minute ventilation was higher (15.54 (13.14-18.48) vs. 12.24 (8.51-13.9) L/min, <i>p</i> < 0.0001) and neural drive was the same (1,163.8 (1,085.5-1,325.5) vs. 1,093.8 (885.7-1,258.7) AU, <i>p</i> = 0.5556).</p><p><strong>Conclusions: </strong>The combination of NIV and ECCO<sub>2</sub>R results in lower work of breathing and improved neuro-ventilatory coupling. NIV fully supports ventilation early whilst ECCO<sub>2</sub>R improves neuro-ventilatory coupling and work of breathing over time.</p><p><strong>Trial registration: </strong>Clinicaltrials.gov; NCT02086084; registered 1 December 2015; https://clinicaltrials.gov/study/NCT02086084?cond=copd&term=ecco2r&rank=4.</p>\",\"PeriodicalId\":10704,\"journal\":{\"name\":\"COPD: Journal of Chronic Obstructive Pulmonary Disease\",\"volume\":\"21 1\",\"pages\":\"2436169\"},\"PeriodicalIF\":2.2000,\"publicationDate\":\"2024-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"COPD: Journal of Chronic Obstructive Pulmonary Disease\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/15412555.2024.2436169\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/12/5 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"RESPIRATORY SYSTEM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"COPD: Journal of Chronic Obstructive Pulmonary Disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/15412555.2024.2436169","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/5 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

摘要

理由:体外二氧化碳去除(ECCO2R)对慢性阻塞性肺疾病(AECOPD)加重期呼吸和通气功的影响尚不清楚。目的:探讨无创通气(NIV)和ECCO2R对AECOPD呼吸驱动、通气力度和通气分布的影响。方法:入选随机对照研究的患者接受食管压力测量、电阻抗断层扫描和胸骨旁肌电图。测量和主要结果:18例患者入组,每组9例。其中,8例NIV组和7例ECCO2R组接受了生理评估。随机分配到ECCO2R组的患者,有一段时间的NIV联合ECCO2R,在移除NIV后,有一段时间的ECCO2R。去除NIV同时继续使用ECCO2R导致呼吸性酸中毒(pH值7.34 (7.31-7.34)vs. 7.31 (7.31-7.34), p p p = 0.0005)。第1天,NIV组呼吸功低于ECCO2R组(4.38(2.76-7.27)比8.03 (4.8-15.94)J/min, p p p = 0.5556)。结论:NIV联合ECCO2R可降低呼吸功,改善神经通气耦合。NIV完全支持早期通气,而ECCO2R随着时间的推移改善神经通气耦合和呼吸工作。试验注册:Clinicaltrials.gov;NCT02086084;2015年12月1日注册;https://clinicaltrials.gov/study/NCT02086084?cond=copd&term=ecco2r&rank=4。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Physiological Assessment of ECCO2R on the Work of Breathing in Exacerbations of COPD.

Rationale: The impact of extracorporeal carbon dioxide removal (ECCO2R) on work of breathing and aeration in exacerbations of chronic obstructive pulmonary disease (AECOPD) is poorly understood.

Objectives: The study explores the impact of non-invasive ventilation (NIV) and ECCO2R on respiratory drive, effort and distribution of ventilation in AECOPD.

Methods: Patients enrolled in a randomised controlled study of the addition of ECCO2R to NIV compared with NIV underwent oesophageal pressure measurement, electrical impedance tomography and parasternal electromyography.

Measurements and main results: 18 patients were enrolled, nine in each arm. Of these, eight in the NIV arm and seven in the ECCO2R arm underwent physiological assessment. Patients randomised to ECCO2R, had a period of NIV combined with ECCO2R and, after removal of NIV, a period of ECCO2R alone. The removal of NIV whilst remaining on ECCO2R resulted in a respiratory acidosis (pH 7.34 (7.31-7.34) vs. 7.31 (7.31-7.34), p < 0.0001), increased work of breathing (7.43 (6.08-10.19) vs. 11.1 (8.11-15.15) J/min, p < 0.0001) and increased neural drive (884.4 (684.7-967.3) vs. 1321.1 (903.3-1575.3) AU, p = 0.0005). On day 1, the work of breathing was lower in the NIV than the ECCO2R group (4.38 (2.76-7.27) vs. 8.03 (4.8-15.94) J/min, p < 0.0001), minute ventilation was higher (15.54 (13.14-18.48) vs. 12.24 (8.51-13.9) L/min, p < 0.0001) and neural drive was the same (1,163.8 (1,085.5-1,325.5) vs. 1,093.8 (885.7-1,258.7) AU, p = 0.5556).

Conclusions: The combination of NIV and ECCO2R results in lower work of breathing and improved neuro-ventilatory coupling. NIV fully supports ventilation early whilst ECCO2R improves neuro-ventilatory coupling and work of breathing over time.

Trial registration: Clinicaltrials.gov; NCT02086084; registered 1 December 2015; https://clinicaltrials.gov/study/NCT02086084?cond=copd&term=ecco2r&rank=4.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
4.40
自引率
0.00%
发文量
38
审稿时长
6-12 weeks
期刊介绍: From pathophysiology and cell biology to pharmacology and psychosocial impact, COPD: Journal Of Chronic Obstructive Pulmonary Disease publishes a wide range of original research, reviews, case studies, and conference proceedings to promote advances in the pathophysiology, diagnosis, management, and control of lung and airway disease and inflammation - providing a unique forum for the discussion, design, and evaluation of more efficient and effective strategies in patient care.
期刊最新文献
Biologic Therapies for Chronic Obstructive Pulmonary Disease: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials. Granzyme B May Act as an Effector Molecule to Control the Inflammatory Process in COPD. Guidelines for the Pharmacologic Treatment of COPD 2023: Canada versus GOLD. The Role of Bioactive Small Molecules in COPD Pathogenesis. Assessment of the Relationship Between Genetic Determinants of Obesity, Unhealthy Eating Habits and Chronic Obstructive Pulmonary Disease: A Mendelian Randomisation Study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1